Structure of the lipopeptide antibiotic tsushimycin

被引:34
作者
Bunkóczi, G
Vértesy, L
Sheldrick, GM
机构
[1] Aventis Pharma Deutschland GmbH, Div Nat Prod LG, D-65926 Frankfurt, Germany
[2] Univ Gottingen, Lehstruhl Strukturchem, D-37077 Gottingen, Germany
来源
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY | 2005年 / 61卷
关键词
D O I
10.1107/S0907444905017270
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The amphomycin derivative tsushimycin has been crystallized and its structure determined at 1.0 angstrom resolution. The asymmetric unit contains 12 molecules and with 1300 independent atoms this structure is one of the largest solved using ab initio direct methods. The antibiotic is comprised of a cyclodecapeptide core, an exocyclic amino acid and a fatty-acid residue. Its backbone adopts a saddle-like conformation that is stabilized by a Ca2+ ion bound within the peptide ring and accounts for the Ca2+-dependence of this antibiotic class. Additional Ca2+ ions link the antibiotic molecules to dimers that enclose an empty space resembling a binding cleft. The dimers possess a large hydrophobic surface capable of interacting with the bacterial cell membrane. The antibiotic daptomycin may exhibit a similar conformation, as the amino-acid sequence is conserved at positions involved in Ca2+ binding.
引用
收藏
页码:1160 / 1164
页数:5
相关论文
共 24 条
[1]   DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS [J].
ALBORN, WE ;
ALLEN, NE ;
PRESTON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2282-2287
[2]   INHIBITION OF PEPTIDOGLYCAN BIOSYNTHESIS IN GRAM-POSITIVE BACTERIA BY LY146032 [J].
ALLEN, NE ;
HOBBS, JN ;
ALBORN, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1093-1099
[3]   NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin [J].
Ball, LJ ;
Goult, CM ;
Donarski, JA ;
Micklefield, J ;
Ramesh, V .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (13) :1872-1878
[4]   In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers [J].
Barry, AL ;
Fuchs, PC ;
Brown, SD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1919-1922
[5]   The antiviral antibiotic feglymycin:: First direct-methods solution of a 1000+equal-atom structure [J].
Bunkóczi, G ;
Vértesy, L ;
Sheldrick, GM .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (09) :1340-1342
[6]   LIPOTEICHOIC ACID AS A NEW TARGET FOR ACTIVITY OF ANTIBIOTICS - MODE OF ACTION OF DAPTOMYCIN (LY146032) [J].
CANEPARI, P ;
BOARETTI, M ;
LLEO, MD ;
SATTA, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :1220-1226
[7]   ENZYMATIC AND CHEMICAL MODIFICATIONS OF LIPOPEPTIDE ANTIBIOTIC A21978C - THE SYNTHESIS AND EVALUATION OF DAPTOMYCIN (LY146032) [J].
DEBONO, M ;
ABBOTT, BJ ;
MOLLOY, RM ;
FUKUDA, DS ;
HUNT, AH ;
DAUPERT, VM ;
COUNTER, FT ;
OTT, JL ;
CARRELL, CB ;
HOWARD, LC ;
BOECK, LD ;
HAMILL, RL .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1093-1105
[8]   Ab initio structure solution of a dimeric cytochrome c3 from Desulfovibrio gigas containing disulfide bridges [J].
Frazao, C ;
Sieker, L ;
Sheldrick, G ;
Lamzin, V ;
LeGall, J ;
Carrondo, MA .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 1999, 4 (02) :162-165
[9]  
HEINEMANN B, 1953, ANTIBIOT CHEMOTHER, V3, P1239
[10]   Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin [J].
Jung, D ;
Rozek, A ;
Okon, M ;
Hancock, REW .
CHEMISTRY & BIOLOGY, 2004, 11 (07) :949-957